Article
Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina.
Epilepsy research - 1 Dec 2019
Pejanovic-Skobic Natasa, Markovic Ivana, Bozina Nada, Basic Silvio
Abstract excerpt
OBJECTIVE: We assessed the influence of the SCN2A gene polymorphism c.56 G > A rs17183814 on the response to lamotrigine monotherapy in patients with focal epilepsy in Herzegovina area, Bosnia and Herzegovina. MATERIAL AND METHODS: For SCN2A polymorphism c.56 G > A rs17183814, one hundred patients with epilepsy who were receiving lamotrigine in monotherapy and seventy-one age and sex matched healthy controls were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.